Score Overview
Explore the 2021 public Archive ranking →
Where Bio-Rad Laboratories Inc has ranked, year by year
Showing 5 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- BIO
1996: 52.3% · 2021: 4.6% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-28 | $ 377.69 | — |
1 Year2025-09-26 | $ 271.36 | 39.18% |
5 Years2021-09-28 | $ 753.03 | -49.84% |
10 Years2016-09-28 | $ 162.26 | 132.77% |
20 Years2006-09-28 | $ 71.74 | 426.47% |
30 Years1996-09-27 | $ 14.38 | 26x |
| Period | Last Price2026-09-28 | 1 Year2025-09-26 | 5 Years2021-09-28 | 10 Years2016-09-28 | 20 Years2006-09-28 | 30 Years1996-09-27 |
|---|---|---|---|---|---|---|
| Price | $ 377.69 | $ 271.36 | $ 753.03 | $ 162.26 | $ 71.74 | $ 14.38 |
| Return | — | 39.18% | -49.84% | 132.77% | 426.47% | 26x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 2.58B | $ 222M | $ 1.61B |
| 2025 | $ 2.58B | $ 759M | $ 1.54B |
| 2024 | $ 2.56B | -$ 1.84B | $ 1.66B |
| 2023 | $ 2.67B | -$ 637M | $ 1.60B |
| 2022 | $ 2.80B | -$ 3.62B | $ 1.79B |
| 2021 | $ 2.92B | $ 4.25B | $ 869M |
| 2020 | $ 2.54B | $ 3.81B | $ 991M |
| 2019 | $ 2.31B | $ 1.75B | $ 1.11B |
| 2018 | $ 2.29B | $ 360M | $ 844M |
| 2017 | $ 2.16B | $ 114M | $ 754M |
| 2016 | $ 2.06B | $ 28M | $ 839M |
| 2015 | $ 2.01B | $ 113M | $ 786M |
| 2014 | $ 2.17B | $ 88M | $ 697M |
| 2013 | $ 2.13B | $ 77M | $ 608M |
| 2012 | $ 2.06B | $ 169M | $ 921M |
| 2011 | $ 2.07B | $ 178M | $ 813M |
| 2010 | $ 1.92B | $ 185M | $ 1.02B |
| 2009 | $ 1.78B | $ 144M | $ 744M |
| 2008 | $ 1.76B | $ 89M | $ 243M |
| 2007 | $ 1.46B | $ 92M | $ 223M |
| 2006 | $ 1.27B | $ 103M | $ 488M |
| 2005 | $ 1.18B | $ 81M | $ 413M |
| 2004 | $ 1.09B | $ 68M | $ 361M |
| 2003 | $ 1.00B | $ 76M | $ 148M |
| 2002 | $ 892M | $ 67M | $ 27M |
| 2001 | $ 817M | $ 44M | $ 47M |
| 2000 | $ 725M | $ 31M | $ 13M |
| 1999 | $ 549M | $ 11M | $ 17M |
| 1998 | $ 441M | $ 24M | $ 10M |
| 1997 | $ 426M | $ 16M | $ 10M |
| 1996 | $ 418M | $ 26M | $ 9M |
| 1995 | $ 396M | $ 25M | $ 14M |
| 1994 | $ 355M | $ 15M | $ 3M |
| 1993 | $ 328M | $ 2M | $ 3M |
| 1992 | $ 330M | $ 15M | $ 2M |
| 1991 | $ 310M | $ 8M | $ 4M |
| 1990 | $ 286M | $ 10M | $ 2M |
| 1989 | $ 236M | $ 10M | $ 2M |
| 1988 | $ 198M | $ 9M | $ 4M |
| 1987 | $ 159M | $ 7M | $ 1M |
| 1986 | $ 126M | $ 6M | $ 2M |
| 1985 | $ 102M | $ 4M | $ 6M |
Bio-Rad Laboratories Inc fundamental performance
Between 2015 and 2025, revenue grew from $ 2.01B to $ 2.58B and net income grew from $ 113M to $ 759M. Revenue increased in 7 of those 10 years; net income in 7.
Across Bio-Rad Laboratories Inc's full reported history, from 1985 to 2025, revenue grew from $ 102M to $ 2.58B and net income grew from $ 4M to $ 759M. Revenue increased in 85% of the years measured; net income in 66%.
Bio-Rad Laboratories Inc currently holds a 20-year HDB Score of 5.1 out of 10. How the HDB Score is calculated.
Membership
Continue BIO’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,816 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
